Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial
Araştırma sonucu: Dergi katkısı › Makale › bilirkişi
15Alıntılar
(Scopus)
Parmak izi
Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial' araştırma başlıklarına git. Birlikte benzersiz bir parmak izi oluştururlar.
Keyphrases
Medicine and Dentistry
Pharmacology, Toxicology and Pharmaceutical Science